Interim safety summary of alemtuzumab vs. chlorambucil as front-line therapy for patients with progressive B-cell chronic lymphocytic leukemia (BCLL) This is an ASCO Meeting Abstract from the 2004 ...
Intelliport System Cleared to Improve IV Bolus Management BD announced that the Food and Drug Administration (FDA) has cleared the BD Intelliport Medication Management System, a management system for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback